Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 3.092M
March 31, 2026 5.297M
December 31, 2025 2.764M
September 30, 2025 2.681M
June 30, 2025 3.168M
March 31, 2025 3.361M
December 31, 2024 3.361M
September 30, 2024 3.636M
June 30, 2024 3.094M
March 31, 2024 2.965M
December 31, 2023 4.386M
September 30, 2023 4.166M
June 30, 2023 3.951M
March 31, 2023 4.227M
Date Value
December 31, 2022 3.201M
September 30, 2022 3.998M
June 30, 2022 7.684M
March 31, 2022 6.748M
December 31, 2021 7.316M
September 30, 2021 9.070M
June 30, 2021 10.60M
March 31, 2021 11.25M
December 31, 2020 15.41M
September 30, 2020 13.81M
June 30, 2020 14.70M
March 31, 2020 11.77M
December 31, 2019 9.364M
September 30, 2019 9.943M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Zymeworks, Inc. 316.60M
Rhythm Pharmaceuticals, Inc. 219.96M
Onconetix, Inc. 2.956M
ACADIA Pharmaceuticals, Inc. 436.29M
Alnylam Pharmaceuticals, Inc. 4.205B

Total Liabilities (Quarterly) Related Metrics